Hemogenyx Pharmaceuticals PLC Announces Full FDA Review for HEMO-CAR-T IND

LONDON, UK / ACCESSWIRE / July 10, 2023 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the Company has received a full review letter from the U.S. …